PH is a rare condition with high mortality rate after pediatric HSCT. As clinical presentation is non-specific and may mimic other conditions, a high degree of suspicion is required for diagnosis. Here, we present a patient with stage-IV neuroblastoma who developed PAH after autologous HSCT. After exclusion of other causes of PH, we regarded that this condition was secondary to HSCT.
Keywords: children; hematopoietic stem cell transplantation; pulmonary hypertension.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.